Kenya - English - Pharmacy and Poisons Board

lords healthcare limited ground floor capitol hill towers cathedral road - azithromycin 1g fluconazole 150mg secnidazole 1g - tablet - azithromycin 1g fluconazole 150mg secnidazole 1g - antibacterials for systemic use: macrolides

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع البتراء للمواد الطبية - petra drug store - mesalazine 1 g - 1 g

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurocept international b.v. - cefazolin sodium - eq. cefazolin 1 g - powder for solution for injection - 1 g - cefazolin sodium - cefazolin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amdipharm ltd. - erythromycin lactobionate - eq. erythromycin 1 g - powder for solution for injection - 1 g - erythromycin lactobionate - erythromycin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr. falk pharma uk ltd - mesalazine - suppository - 1gram

Malta - English - Malta Medicines Authority

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - powder for solution for injection/infusion - cefepime 1 g - antibacterials for systemic use

Malta - English - Malta Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - meropenem trihydrate - powder for solution for infusion or injection - meropenem trihydrate 1 g - antibacterials for systemic use

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefotaxime sodium 1048.1mg equivalent 1 g cefotaxime (+ 5% overage) - powder for injection - 1 g - active: cefotaxime sodium 1048.1mg equivalent 1 g cefotaxime (+ 5% overage) - cefotaxime is indicated in the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity. · septicaemia. · respiratory tract infections: acute and chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and post-operative chest infections. · urinary tract infections: acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. · soft tissue infections: cellulitis, peritonitis and wound infections. · bone and joint infections: osteomyelitis, septic arthritis. · obstetric and gynaecological infections: pelvic inflammatory disease. · gonorrhoea: particularly if penicillin-resistant. · other bacterial infections: meningitis and other sensitive infections suitable for parenteral antibiotic therapy. the administration of cefotaxime prophylactically may reduce the incidence of certain post-operative infections in patients undergoing surgical procedures that are classified as contaminated or potentially contaminated or in clean operations where infections would have serious effects. protection is best ensured by achieving adequate local tissue concentrations at the time contamination is likely to occur. cefotaxime should therefore be administered immediately prior to surgery and if necessary continued in the immediate post-operative period. administration should usually be stopped within 24 hours since continuing use of any antibiotic in the majority of surgical procedures does not reduce the incidence of subsequent infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - cefoxitin sodium 1 g - powder for injection - 1 g - active: cefoxitin sodium 1 g - cefoxitin actavis is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology) peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. cefoxitin actavis has a high degree of stability against beta-lactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. cefoxitin actavis can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefepime dihydrochloride monohydrate 1 g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1 g excipient: arginine - indicated for the treatment of lower respiratory tract infections, including pneumonia and bronchitis, when caused by susceptible bacteria.